Jindan Luo

844 total citations
42 papers, 604 citations indexed

About

Jindan Luo is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jindan Luo has authored 42 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jindan Luo's work include Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers) and Prostate Cancer Treatment and Research (8 papers). Jindan Luo is often cited by papers focused on Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers) and Prostate Cancer Treatment and Research (8 papers). Jindan Luo collaborates with scholars based in China, United States and Canada. Jindan Luo's co-authors include Liping Xie, Xiangyi Zheng, Xin Xu, Yeqing Mao, Xianglai Xu, Zhenghui Hu, Jian Wu, Yiwei Lin, Shiqi Li and Hong Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Jindan Luo

36 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jindan Luo China	13	444	332	86	83	65	42	604
Daisuke Iitaka Japan	12	385 0.9×	275 0.8×	90 1.0×	100 1.2×	70 1.1×	23	548
Ruifen Dong China	15	419 0.9×	360 1.1×	65 0.8×	44 0.5×	111 1.7×	22	685
Chengyong Lei China	11	294 0.7×	136 0.4×	74 0.9×	79 1.0×	94 1.4×	18	433
Huiyue Dong China	14	302 0.7×	158 0.5×	76 0.9×	65 0.8×	60 0.9×	20	485
Shounan Lu China	10	335 0.8×	324 1.0×	49 0.6×	62 0.7×	71 1.1×	30	499
Hongbing Mei China	16	423 1.0×	371 1.1×	92 1.1×	60 0.7×	108 1.7×	45	650
Xiaobo Yu China	11	317 0.7×	229 0.7×	58 0.7×	57 0.7×	97 1.5×	14	472
Shikai Zhu China	14	341 0.8×	211 0.6×	81 0.9×	80 1.0×	159 2.4×	30	546
Changbao Qu China	13	475 1.1×	333 1.0×	76 0.9×	47 0.6×	81 1.2×	28	625

Countries citing papers authored by Jindan Luo

Since Specialization

Citations

This map shows the geographic impact of Jindan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jindan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jindan Luo more than expected).

Fields of papers citing papers by Jindan Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jindan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jindan Luo. The network helps show where Jindan Luo may publish in the future.

Co-authorship network of co-authors of Jindan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jindan Luo. A scholar is included among the top collaborators of Jindan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jindan Luo. Jindan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiaming, Haiyun Xie, Zixiang Liu, et al.. (2025). KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway. Cell Reports. 44(5). 115595–115595.

Chen, Shengcai, Zhimin Zhou, Zhen You, et al.. (2025). The urinary eccDNA landscape in prostate cancer reveals associations with genome instability and vital roles in cancer progression. Journal of Advanced Research. 77. 637–652. 5 indexed citations

Matveev, Vsevolod, Xin Gao, Evgeny Kopyltsov, et al.. (2024). PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer. Asia-Pacific Journal of Clinical Oncology. 20(6). 738–746.

Shu, Xuan, Jiaming Wang, Wen Cai, et al.. (2024). Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study. World Journal of Surgical Oncology. 22(1). 355–355.

Shu, Xuan, Jiangfeng Li, Yufan Ying, et al.. (2024). N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. Cellular Signalling. 125. 111510–111510. 8 indexed citations

Shen, Haixiang, Yufan Ying, Xueyou Ma, et al.. (2022). FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway. Cell Death Discovery. 8(1). 356–356. 14 indexed citations

Huang, Yujie, et al.. (2022). Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance. Drug Design Development and Therapy. Volume 16. 3817–3828. 1 indexed citations

Hu, Xingjiang, Qiao Zhang, Yunliang Zheng, et al.. (2022). A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects. Frontiers in Pharmacology. 13. 946505–946505. 1 indexed citations

Fu, Jing, et al.. (2021). Testicular and Spermatic Cord Metastases from Gastric Adenocarcinoma: An Unusual Case. Cancer Management and Research. Volume 13. 1897–1900. 3 indexed citations

10.

Luo, Jindan, Nitin Shivappa, James R. Hébert, & Xin Xu. (2020). Dietary inflammatory index and bladder cancer risk: a prospective study. European Journal of Clinical Nutrition. 74(10). 1428–1433. 9 indexed citations

11.

Qi, Hongyan, Xinxin Ke, Xueping Xiang, et al.. (2020). STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis. Oncogenesis. 9(2). 15–15. 29 indexed citations

12.

Luo, Jindan & Xin Xu. (2019). Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort. Carcinogenesis. 41(4). 478–482. 10 indexed citations

13.

Luo, Jindan, Yinan Li, Wei Zheng, et al.. (2019). Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene. Molecular Therapy — Nucleic Acids. 18. 916–926. 31 indexed citations

14.

Luo, Jindan, Jie Luo, Chong Lai, Jun Chen, & Hongzhou Meng. (2018). Is use of vitamin K antagonists associated with the risk of prostate cancer?. Medicine. 97(49). e13489–e13489. 4 indexed citations

15.

Chen, Shanwen, et al.. (2014). Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancer. OncoTargets and Therapy. 7. 2137–2137. 6 indexed citations

16.

Li, Shiqi, Xianglai Xu, Xin Xu, et al.. (2013). MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochemical and Biophysical Research Communications. 441(4). 976–981. 58 indexed citations

17.

Liu, Ben, Jun Chen, Jindan Luo, et al.. (2013). Cavernous hemangioma of the testis mimicking a testicular teratoma. Experimental and Therapeutic Medicine. 6(1). 91–92. 8 indexed citations

18.

Chen, Jun, Dan Xia, Jindan Luo, & Ping Wang. (2009). Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells. Asian Journal of Andrology. 11(6). 669–677. 10 indexed citations

19.

Wang, Ping, et al.. (2009). Nkx3.1 and p27^KIP1Cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells. Cancer Investigation. 27(4). 369–375. 14 indexed citations

20.

Wang, Ping, et al.. (2007). Expression of Nkx3.1 enhances 17?-estradiol anti-tumor action in PC3 human prostate cancer cells. Asian Journal of Andrology. 9(3). 353–360. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact